These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. High dose chemotherapy and autologous stem cell transplantation in patients with peripheral T-cell lymphoma not achieving complete response after induction chemotherapy. The GEL-TAMO experience. Rodriguez J; Caballero MD; Gutierrez A; Gandarillas M; Sierra J; Lopez-Guillermo A; Sureda A; Zuazu J; Marin J; Arranz R; Carreras E; Leon A; De Sevilla AF; San Miguel JF; Conde E; Haematologica; 2003 Dec; 88(12):1372-7. PubMed ID: 14687990 [TBL] [Abstract][Full Text] [Related]
6. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)]. Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687 [TBL] [Abstract][Full Text] [Related]
7. [Combination of high-dose chemotherapy with autologous hematopoietic stem cell transplantation for recurrent and high-risk breast cancer: a pilot study]. Shi Y; Pan F; Han X Zhonghua Yi Xue Za Zhi; 1999 Dec; 79(12):890-3. PubMed ID: 11715500 [TBL] [Abstract][Full Text] [Related]
8. [Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003]. Jacomet C; Lesens O; Villemagne B; Darcha C; Tournilhac O; Henquell C; Cormerais L; Gourdon F; Peigue-Lafeuille H; Travade P; Beytout J; Laurichesse H Med Mal Infect; 2006 Mar; 36(3):157-62. PubMed ID: 16503104 [TBL] [Abstract][Full Text] [Related]
9. Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation. Schetelig J; Fetscher S; Reichle A; Berdel WE; Beguin Y; Brunet S; Caballero D; Majolino I; Hagberg H; Johnsen HE; Kimby E; Montserrat E; Stewart D; Copplestone A; Rösler W; Pavel J; Kingreen D; Siegert W Haematologica; 2003 Nov; 88(11):1272-8. PubMed ID: 14607756 [TBL] [Abstract][Full Text] [Related]
10. Report of AIDS-related lymphoma in South Korea. Kim JS; Kim SJ; Kim JS; Kim ES; Shin HJ; Chung JS; Min YH; Lee MH; Choi YJ; Bang SM; Kim JA; Cho GJ; Chi HS; Jang SS; Park CJ; Suh C; Park CW; Kim CS; Jpn J Clin Oncol; 2008 Feb; 38(2):134-9. PubMed ID: 18263652 [TBL] [Abstract][Full Text] [Related]
11. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study. Simcock M; Blasko M; Karrer U; Bertisch B; Pless M; Blumer L; Vora S; Robinson JO; Bernasconi E; Terziroli B; Moirandat-Rytz S; Furrer H; Hirschel B; Vernazza P; Sendi P; Rickenbach M; Bucher HC; Battegay M; Koller MT; Antivir Ther; 2007; 12(6):931-9. PubMed ID: 17926647 [TBL] [Abstract][Full Text] [Related]
12. Activity of single-agent melphalan 220-300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma. Phillips GL; Meisenberg BR; Reece DE; Adams VR; Badros AZ; Brunner JL; Fenton RG; Filicko J; Grosso DL; Hale GA; Howard DS; Johnson VP; Kniska A; Marshall KW; Mookerjee B; Nath R; Rapoport AP; Sarkodee-Adoo C; Takebe N; Vesole DH; Wagner JL; Flomenberg N Bone Marrow Transplant; 2004 Apr; 33(8):781-7. PubMed ID: 14767498 [TBL] [Abstract][Full Text] [Related]
13. 'Relative' chemotherapy sensitivity: the impact of number of salvage regimens prior to autologous stem cell transplant for relapsed and refractory aggressive non-Hodgkin's lymphoma. Chen CI; Roitman D; Tsang R; Stewart AK; Keating A; Crump M Bone Marrow Transplant; 2002 Dec; 30(12):885-91. PubMed ID: 12476281 [TBL] [Abstract][Full Text] [Related]
14. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy. Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411 [TBL] [Abstract][Full Text] [Related]
15. Immune recovery after autologous stem cell transplantation is not different for HIV-infected versus HIV-uninfected patients with relapsed or refractory lymphoma. Simonelli C; Zanussi S; Pratesi C; Rupolo M; Talamini R; Caffau C; Teresa Bortolin M; Tedeschi R; Basaglia G; Mazzucato M; Manuele R; Vaccher E; Spina M; Tirelli U; Michieli M; De Paoli P Clin Infect Dis; 2010 Jun; 50(12):1672-9. PubMed ID: 20450419 [TBL] [Abstract][Full Text] [Related]
16. A novel approach to HIV therapy: highly active antiretroviral therapy and autologous hematopoietic cell transplantation. Pippi F Med Hypotheses; 2008; 70(2):291-3. PubMed ID: 17681707 [TBL] [Abstract][Full Text] [Related]
17. High-dose therapy and autologous stem cell transplantation for children with HIV-associated non-Hodgkin lymphoma. Fluri S; Ammann R; Lüthy AR; Hirt A; Aebi C; Duppenthaler A; Leibundgut K Pediatr Blood Cancer; 2007 Dec; 49(7):984-7. PubMed ID: 16685736 [TBL] [Abstract][Full Text] [Related]
19. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas. Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557 [TBL] [Abstract][Full Text] [Related]
20. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma]. Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]